The final stages of the global eradication of poliomyelitis
- PMID: 23798688
- PMCID: PMC3720038
- DOI: 10.1098/rstb.2012.0140
The final stages of the global eradication of poliomyelitis
Abstract
The global incidence of poliomyelitis has dropped by more than 99 per cent since the governments of the world committed to eradication in 1988. One of the three serotypes of wild poliovirus has been eradicated and the remaining two serotypes are limited to just a small number of endemic regions. However, the Global Polio Eradication Initiative (GPEI) has faced a number of challenges in eradicating the last 1 per cent of wild-virus transmission. The polio endgame has also been complicated by the recognition that vaccination with the oral poliovirus vaccine (OPV) must eventually cease because of the risk of outbreaks of vaccine-derived polioviruses. I describe the major challenges to wild poliovirus eradication, focusing on the poor immunogenicity of OPV in lower-income countries, the inherent limitations to the sensitivity and specificity of surveillance, the international spread of poliovirus and resulting outbreaks, and the potential significance of waning intestinal immunity induced by OPV. I then focus on the challenges to eradicating all polioviruses, the problem of vaccine-derived polioviruses and the risk of wild-type or vaccine-derived poliovirus re-emergence after the cessation of oral vaccination. I document the role of research in the GPEI's response to these challenges and ultimately the feasibility of achieving a world without poliomyelitis.
Keywords: eradication; polio; poliomyelitis; poliovirus; public health; vaccine.
Figures



Similar articles
-
Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.Pediatrics. 2015 Jan;135(1):196-202. doi: 10.1542/peds.2014-3163. Pediatrics. 2015. PMID: 25548328
-
Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative.Am J Epidemiol. 1999 Nov 15;150(10):1001-21. doi: 10.1093/oxfordjournals.aje.a009924. Am J Epidemiol. 1999. PMID: 10568615 Review.
-
Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPV.Risk Anal. 2021 Feb;41(2):312-319. doi: 10.1111/risa.13590. Epub 2020 Sep 16. Risk Anal. 2021. PMID: 32936466 Free PMC article.
-
The polio endgame.Hum Vaccin Immunother. 2014;10(7):2106-8. doi: 10.4161/21645515.2014.981115. Hum Vaccin Immunother. 2014. PMID: 25608050 Free PMC article. Review.
-
Polio Eradication and Endgame Plan - Victory within Grasp.Indian Pediatr. 2016 Aug 7;53 Suppl 1:S28-S32. Indian Pediatr. 2016. PMID: 27771636
Cited by
-
The influence of compositional and contextual factors on non-receipt of basic vaccines among children of 12-23-month old in India: a multilevel analysis.PLoS One. 2014 Sep 11;9(9):e106528. doi: 10.1371/journal.pone.0106528. eCollection 2014. PLoS One. 2014. PMID: 25211356 Free PMC article.
-
Impact of mosquito gene drive on malaria elimination in a computational model with explicit spatial and temporal dynamics.Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):E255-E264. doi: 10.1073/pnas.1611064114. Epub 2016 Dec 27. Proc Natl Acad Sci U S A. 2017. PMID: 28028208 Free PMC article.
-
Economic considerations for the eradication endgame.Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120149. doi: 10.1098/rstb.2012.0149. Print 2013 Aug 5. Philos Trans R Soc Lond B Biol Sci. 2013. PMID: 23798697 Free PMC article.
-
Epidemiology of the silent polio outbreak in Rahat, Israel, based on modeling of environmental surveillance data.Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10625-E10633. doi: 10.1073/pnas.1808798115. Epub 2018 Oct 18. Proc Natl Acad Sci U S A. 2018. PMID: 30337479 Free PMC article.
-
Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment.J Clin Immunol. 2018 Jul;38(5):628-634. doi: 10.1007/s10875-018-0531-x. Epub 2018 Jul 14. J Clin Immunol. 2018. PMID: 30006913
References
-
- Fine PEM, Carneiro IAM. 1999. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. Am. J. Epidemiol. 150, 1001–102110.1093/oxfordjournals.aje.a009924 (doi:10.1093/oxfordjournals.aje.a009924) - DOI - DOI - PubMed
-
- World Health Organisation 1988. Global eradication of poliomyelitis by the year 2000. Forty-first World Health Assembly resolution WHA41.28. Geneva, Switzerland: WHO
-
- Sutter RW, Kew OM, Cochi SL. 2008. Poliovirus vaccine - live. In Vaccines (eds Plotkin SA, Orenstein WA.), pp. 651–705, 5th edn Philadelphia, PA: Saunders
-
- Ogra PL, Karzon DT, Righthan F, Macgilli M. 1968. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N. Engl. J. Med. 279, 893–90010.1056/NEJM196810242791701 (doi:10.1056/NEJM196810242791701) - DOI - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical